DONATE/Buy Art

Donate now

Contact us

ZATA Project
9763 East Crestline Circle
Greenwood Village, Colorado 80111

Email


 Learn more about us


Interview with Africa Agenda 


 

 


 

Our 10th Anniversary Auction was a Blast!


It was a special night of beautiful art and sculpture from Zimbabwe and fantastic Zimbabwe music from the Boulder-based ZIMbira and its lead vocalist, Zivanai. An enormous thank you to the 110 ZATA art lovers and donors who contributed to a highly successful 10 year Zimbabwe Art and Sculpture auction at the Fulginiti Pavilion on the Anschutz Medical Campus on December 2, 2014.  ZATA has now raised over $320,000 for AIDS medications, staffing support at the AIDS Research Center at the University of Zimbabwe (UZ), a clean water well at UZ to stave off the cholera outbreak and educational support for AIDS orphans. Recently, we have selected the clinical research grants of three young research faculty at UZ who are involved in two interesting HIV-related projects as well as a microloan for 10 HIV-infected women in rural Zimbabwe who are committed to expanding their broccoli farms and reaching self-sufficiency.

ZATA also thanks David Weil from the Fulginiti Pavilion who worked so hard on helping us with the hanging of the art and the auction, as well as the enormously generous framers in the Denver area who donate their materials and labor so that the Zimbabwe paintings “pop”!  There are only a few paintings and sculpture that did not sell, but they were in our estimation some of the best artwork in the auction. If you are interested in seeing them, please contact us at  email@zataproject.org, and we will give you a private showing.


 

HIV Research Projects and Broccoli Farms...

Click here or on "ZATA News" to learn more about our new projects in 2014


 

 The ZATA Project

Fortunately, HIV prevalence has been declining in Zimbabwe: it was 27% in 1997, 24% in 2001, 18% in 2005, and 14% in 2009. Yet, fewer than half of Zimbabwean AIDS patients have access to the life-saving antiretroviral treatments for HIV/AIDS, and more th an 10% of all such treatment that is provided in this country of about 12 million people is provided through the research programs at the University of Zimbabwe Medical School Clinical Research Centre. Because of its generous donors and art buyers since 2004, the ZATA Project is now serving over 900 HIV-infected patients at the University of Zimbabwe and helping them return to a productive live with their families.

Doctors from the University of Colorado Denver and the University of California at San Diego collaborate with investigators at the University of Zimbabwe in on-going research to improve the care and treatment of people with AIDS in Zimbabwe. Over the past several years, this collaboration has resulted in funding from a number of organizations, including the National Institutes of Health, and pharmaceutical companies, among others, to conduct research studies to find the most effective combination of antiretroviral drugs to treat Zimbabwean AIDS patients. However, once patients in the study complete their role, they must purchase the drugs on their own. Most cannot afford to purchase the drugs to continue treatment. While the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) has recently provided significant support to Zimbabwe for HIV medications, many HIV-infected patients still do not have access to life-saving drugs. Further, because of the country’s economic issues, the health institutions are often woefully short of funds to pay for professional staff and supplies.

The ZATA (Zimbabwe AIDS Treatment Assistance) Project was founded as a 501(c)3 non-profit organization in 2004 in cooperation with University of Colorado Denver AIDS experts to raise funds through the sale and auction of Zimbabwean art and sculpture. The major propose of the ZATA Project is to provide antiretroviral drugs and medical care to HIV/AIDS-infected patients once they have completed their role in the medical research studies by closely working with the University of Zimbabwe medical faculty to purchase the most cost-effective therapies that will help the most people.